Theraclion (XPAR:ALTHE) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALTHE Theraclion XPAR:ALTHE
27 GF Score
Price €0.58
GF Value €0.26
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Theraclion FFO?

FFO (Funds from operations) only applies to REITs.

XPAR:ALTHE
27GF Score
Theraclion XPAR:ALTHE
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Theraclion (XPAR:ALTHE) Overvalued in 2026?

Based on GuruFocus' analysis, Theraclion stock appears to be overvalued. The current stock price of €0.58 is trading 123.5% above its estimated GF Value™ of €0.26. GuruFocus considers Theraclion to be Significantly Overvalued.

Key valuation signals for XPAR:ALTHE:

  • FFO:
  • GF Value™: €0.26 vs. price of €0.58 (123.5% above fair value)
  • GF Score™: 27/100 with 7 warning signs

No single metric tells the full story. See the XPAR:ALTHE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Theraclion Business Description

Other Exchanges 941:Germany
Address 244 Avenue Pierre Brossolette, Immeuble Le Vaillant, Malakoff, Paris, FRA, 92240
Theraclion specializes in developing, manufacturing, and marketing echotherapy equipment, associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules. Its products include Sonovein, Echopulse, and Epack.
27GF Score

Get the complete analysis for XPAR:ALTHE

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.58
Price
€0.26
GF Value